The global digital x-ray devices market was surpassed at USD 11.16 billion in 2021 and is expected to hit around USD 22.74 billion by 2030, growing at a CAGR of 8.23% from 2022 to 2030.
Market Synopsis
Radiography utilising x-rays is the first step in diagnosing or screening for a number of health conditions.X-ray technology is more frequently used in the medical industry due to its low cost. It is non-invasive, safe, and quickly produces the images required to effectively diagnose issues. The issues associated with traditionally x-ray technology include the expenses of maintaining the hardware required to process the images as well as the inconvenience of storing physical images. Both of these difficulties are resolved by the development of digital x-ray technology, which commenced in the middle of the 1980s.Digital x-ray systems do not require expensive image processing equipment like darkrooms, specialist chemicals, big film processors, specialized film storage, or even x-ray films, in contrast to traditional x-ray devices. Instead, digital x-ray utilizes computer storage media with laser or thermal printers similar to those found in any office environment. This market holds a high growth potential due to a variety of benefits including shorter exposure times, detail detectability, mobility, and real-time applications.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 11.16 billion |
Revenue Forecast by 2030 | USD 22.74 billion |
Growth rate from 2022 to 2030 | CAGR of 8.23% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Portability, Application, End-Use, Region |
Companies Covered |
Philips Healthcare,GE HealthCare, Siemens Healthineers AG, Fujifilm, Carestream Health, others |
Market Influencer
The benefits of digital x-ray devices have been a major factor in driving their adoption by healthcare facilities; the systems' speed and precision, as well as short processing times, enable far higher patient screening volumes. Constant product development and technological innovations such as integration of artificial intelligence, low x-ray dose exposure, high-resolution imaging is contributing to the market growth. For instance, in September 2021, GE Healthcare launched the Definium Tempo, a fixed, overhead tube suspension (OTS) digital X-ray system. This system is intended to be a personal assistant for radiologists and technologist. It uses automation to lighten workloads and support radiology departments in providing the best patient care possible. Government initiatives are expected to further propel the market growth during the forecast period. In July 2022, the European Union (EU) and the WHO donated digital x-ray equipment to the Armenia Ministry of Health for use in the radiology departments of 7 hospitals. The increasing prevalence of chronic disorders, such as cardiovascular diseases (CVDs), asthma, and lung cancer is leading to a growing demand for early diagnosis and treatment. Thus augmenting the adoption of these devices. According to the International Agency for Research on Cancer in 2020, globally 2,206,771 new lung cancer cases were diagnosed with 1,796,144 deaths in the same year.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Digital X-ray Devices Market
5.1. COVID-19 Landscape: Digital X-ray Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Digital X-ray Devices Market, By Portability
8.1. Digital X-ray Devices Market, by Portability, 2022-2030
8.1.1 Fixed
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Mobile
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Digital X-ray Devices Market, By Application
9.1. Digital X-ray Devices Market, by Application, 2022-2030
9.1.1. General Imaging
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Cardiovascular
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Orthopedic
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Dental
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Digital X-ray Devices Market, By End-Use
10.1. Digital X-ray Devices Market, by End-Use, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostics Imaging Centers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Dental Care Centers
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Digital X-ray Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Portability (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Portability (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Portability (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Portability (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Portability (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Portability (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Portability (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Portability (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Portability (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Portability (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Portability (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Portability (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Portability (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Portability (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Portability (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Portability (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Portability (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Portability (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Portability (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Portability (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Portability (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 12. Company Profiles
12.1. Philips Healthcare
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GE HealthCare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Siemens Healthineers AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Fujifilm
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Carestream Health
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. others
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms